Revenue, Patents, and New Generic Competition for Prescription Drugs in the USA

S. Sean Tu, Aaron S. Kesselheim, Joseph S. Ross, Ravi Gupta

Open source

DOI: 10.1007/s11606-025-09717-x
Published: 2025-07-14
Container: Journal of General Internal Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s11606-025-09717-x,
  title = {Revenue, Patents, and New Generic Competition for Prescription Drugs in the USA},
  author = {S. Sean Tu and Aaron S. Kesselheim and Joseph S. Ross and Ravi Gupta},
  year = {2025},
  journal = {Journal of General Internal Medicine},
  doi = {10.1007/s11606-025-09717-x},
  url = {https://doi.org/10.1007/s11606-025-09717-x}
}

RIS

TY  - JOUR
TI  - Revenue, Patents, and New Generic Competition for Prescription Drugs in the USA
AU  - S. Sean Tu
AU  - Aaron S. Kesselheim
AU  - Joseph S. Ross
AU  - Ravi Gupta
PY  - 2025
JO  - Journal of General Internal Medicine
DO  - 10.1007/s11606-025-09717-x
UR  - https://doi.org/10.1007/s11606-025-09717-x
ER  -

APA

Tu, S. S., Kesselheim, A. S., Ross, J. S., & Gupta, R. (2025). Revenue, Patents, and New Generic Competition for Prescription Drugs in the USA. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-025-09717-x

Source records

crossref · retrieved 2026-09-26T18:53:21.498Z